Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125422731 | 12542273 | 1 | I | 20151118 | 20160520 | 20160708 | 20160708 | EXP | US-ELI_LILLY_AND_COMPANY-US201605007652 | ELI LILLY AND CO | 46.25 | YR | F | Y | 45.81000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125422731 | 12542273 | 1 | PS | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | Y | 18936 | 20 | MG | QD | ||||||
| 125422731 | 12542273 | 2 | SS | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Y | 18936 | |||||||||||
| 125422731 | 12542273 | 3 | C | CALCIUM /02801801/ | 2 | Unknown | UNK, UNKNOWN | U | 0 | ||||||||||
| 125422731 | 12542273 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125422731 | 12542273 | 5 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125422731 | 12542273 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 125422731 | 12542273 | 7 | C | BIOTINE /00001702/ | 2 | Unknown | UNK, UNKNOWN | U | 0 | ||||||||||
| 125422731 | 12542273 | 8 | C | BAYER BACK AND BODY EXTRA STRENGTH | ASPIRINCAFFEINE | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125422731 | 12542273 | 1 | Major depression |
| 125422731 | 12542273 | 2 | Generalised anxiety disorder |
| 125422731 | 12542273 | 3 | Product used for unknown indication |
| 125422731 | 12542273 | 4 | Product used for unknown indication |
| 125422731 | 12542273 | 5 | Product used for unknown indication |
| 125422731 | 12542273 | 6 | Product used for unknown indication |
| 125422731 | 12542273 | 7 | Product used for unknown indication |
| 125422731 | 12542273 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125422731 | 12542273 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125422731 | 12542273 | Alanine aminotransferase increased | |
| 125422731 | 12542273 | Aspartate aminotransferase increased | |
| 125422731 | 12542273 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125422731 | 12542273 | 1 | 20150918 | 20151221 | 0 |